NCT00569309 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- Not reported
- Other-event reporting threshold
- 5%
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Prevnar | 0 / 30 | 30 / 30 | 0 / 30 |
Serious adverse events
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- notes
- Upper Respiratory Infection
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE version 3.0
- stats
- group Id
- EG000
- num Affected
- 23
- num At Risk
- 30
- num Events
- 23
- term
- Infection with unknown ANC
- assessment Type
- SYSTEMATIC_ASSESSMENT
- notes
- Pneumo fever with origin unknown
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE version 3.0
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 30
- num Events
- 3
- term
- Infection with unknown ANC
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE version 3.0
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 30
- num Events
- 3
- term
- Fever with unknown origin
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE version 3.0
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 30
- num Events
- 2
- term
- Colitis
Complete source fields
- event Groups
- deaths Num Affected
- 0
- deaths Num At Risk
- 30
- description
- The conjugate vaccine for Streptococcus pneumoniae will be administered during weeks 9, 17, and 25 after autologous HSCT - the study nurse will arrange for the vaccine to be administered at the specified time and the patient will be instructed to notify an investigator or study nurse of any side effects of vaccine administration. Streptococcus pneumoniae: Patients will receive 0.5 mL Prevnar in the deltoid muscle during weeks 9, 17, and 25 after autologous hematopoietic stem cell transplantation (HSCT)
- id
- EG000
- other Num Affected
- 30
- other Num At Risk
- 30
- serious Num Affected
- 0
- serious Num At Risk
- 30
- title
- Prevnar
- frequency Threshold
- 5
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- notes
- Upper Respiratory Infection
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE version 3.0
- stats
- group Id
- EG000
- num Affected
- 23
- num At Risk
- 30
- num Events
- 23
- term
- Infection with unknown ANC
- assessment Type
- SYSTEMATIC_ASSESSMENT
- notes
- Pneumo fever with origin unknown
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE version 3.0
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 30
- num Events
- 3
- term
- Infection with unknown ANC
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE version 3.0
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 30
- num Events
- 3
- term
- Fever with unknown origin
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE version 3.0
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 30
- num Events
- 2
- term
- Colitis
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle